Claritev Corp. (CTEV)
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
$20.22-6.69%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
QuarterlyIQ Insights · CTEV
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -75.2% |
| Our one-year growth estimate | diamond | 5.9% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 81.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has been missing across recent quarters and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 9 industry peers
CTEV — director transition
Dated 2026-10-15
Director — Jennifer Main: The filing discloses the appointment of a new director to fill a newly created seat, which is a routine board composition change rather than an executive departure.
Why it matters: Claritev raised its revenue range after five straight quarters of growth. Meeting the new range would support its expansion into new markets.
Supportive ifFY 2026 revenue is at least $1 billion, within the August range of $1 billion to $1.02 billion.
Worry ifFY 2026 revenue is below $1 billion, or the company lowers its revenue range before year-end.
Why it matters: The next report is close. Q3 results can test whether revenue growth continued and whether Claritev kept its raised 2026 outlook.
Watch forOn November 9, Claritev reports Q3 revenue growth from a year earlier. It keeps its FY 2026 revenue range at $1 billion to $1.02 billion or higher.
Also watch forOn November 9, Q3 revenue falls year over year or Claritev cuts its FY 2026 revenue range below $1 billion.
Why it matters: The August outlook raised the free cash flow range, but the low end is still small. The next report can show whether cash flow improved beyond Q1's loss.
Supportive ifFY 2026 free cash flow is at least $5 million, within the August range of $5 million to $15 million.
Worry ifFY 2026 free cash flow is below $5 million, or the company cuts its August range.
Why it matters: Bookings can signal future sales. Management said first-half bookings topped $70 million and named $100 million as its full-year goal.
Supportive ifClaritev reports at least $100 million in full-year 2026 bookings. Wins span solutions and markets.
Worry ifFull-year bookings are below $100 million. Or later updates show little progress beyond the first-half total of $70 million.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$286 on $10,000 · ±2.9% | How much price usually moves either way. |
| Bad day | $992 loss on $10,000 · 9.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,055 loss on $10,000 · 80.5% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Operating cash flow swung from negative $45.8 million in Q1 to positive $92.7 million in Q2. Another positive quarter would support the cash flow improvement.
Supportive ifQ3 operating activities bring in more than zero net cash.
Worry ifQ3 net cash from operating activities is below zero, as in Q1 2026.